Phase 2 trial of neoadjuvant bevacizumab plus pemetrexed and carboplatin in patients with unresectable stage III lung adenocarcinoma (GASTO 1001).
about
Identification of Key Transcription Factors Associated with Lung Squamous Cell Carcinoma.Neoadjuvant combination chemotherapy for unresectable stage III non-small cell lung cancer.Elevated pretreatment serum lactate dehydrogenase level predicts inferior overall survival and disease-free survival after resection of thymic carcinoma.Before or After: Evolving Neoadjuvant Approaches to Locally Advanced Non-Small Cell Lung Cancer.
P2860
Phase 2 trial of neoadjuvant bevacizumab plus pemetrexed and carboplatin in patients with unresectable stage III lung adenocarcinoma (GASTO 1001).
description
2015 nî lūn-bûn
@nan
2015 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Phase 2 trial of neoadjuvant b ...... g adenocarcinoma (GASTO 1001).
@ast
Phase 2 trial of neoadjuvant b ...... g adenocarcinoma (GASTO 1001).
@en
type
label
Phase 2 trial of neoadjuvant b ...... g adenocarcinoma (GASTO 1001).
@ast
Phase 2 trial of neoadjuvant b ...... g adenocarcinoma (GASTO 1001).
@en
prefLabel
Phase 2 trial of neoadjuvant b ...... g adenocarcinoma (GASTO 1001).
@ast
Phase 2 trial of neoadjuvant b ...... g adenocarcinoma (GASTO 1001).
@en
P2093
P2860
P921
P356
P1433
P1476
Phase 2 trial of neoadjuvant b ...... g adenocarcinoma (GASTO 1001).
@en
P2093
Bao-Xiao Wang
Qian-Wen Liu
Qun-Ai Huang
Si-Yu Wang
P2860
P304
P356
10.1002/CNCR.29800
P407
P577
2015-12-23T00:00:00Z